Predictive value of the early metabolic response in patients with advanced-stage non-small cell lung cancer

Saved in:
Bibliographic Details
Published inRevista espanola de medicina nuclear e imagen molecular Vol. 33; no. 5; p. 324
Main Authors Moreno, C, Mourelo, S, Soler, M, Moragas, M, Riera, E, Garcia, J R
Format Journal Article
LanguageSpanish
Published Spain 01.09.2014
Subjects
Adult
Antineoplastic Agents - therapeutic use
Carcinoma, Non-Small-Cell Lung - diagnosis
Carcinoma, Non-Small-Cell Lung - drug therapy
Carcinoma, Non-Small-Cell Lung - metabolism
Erlotinib Hydrochloride - therapeutic use
Female
Fluorodeoxyglucose F18
Humans
Lung Neoplasms - diagnosis
Lung Neoplasms - drug therapy
Lung Neoplasms - metabolism
Multimodal Imaging
Neoplasm Staging
Positron-Emission Tomography
Predictive Value of Tests
Radiopharmaceuticals
Time Factors
Tomography, X-Ray Computed
Treatment Outcome
Online AccessGet more information

Cover

More Information
ISSN:2253-8070
DOI:10.1016/j.remn.2013.10.013